Chapter 4 - The Ledger of Grace
By six o'clock the next morning, the executive boardroom of Whitmore Enterprises on the eightieth floor of the Willis Tower was filled with the city’s top legal minds, financial analysts, and forensic accountants. I stood at the head of the long glass table, my suit jacket gone, my sleeves rolled up to my elbows, looking like a man who was about to dismantle his own kingdom.
"Mr. Whitmore, this is unprecedented," my chief financial officer, a man who had managed my portfolio for fifteen years, said, his voice trembling as he looked at the directives I had laid out on the digital screen. "You want to liquidate forty percent of our commercial real estate holdings in downtown Chicago within forty-eight hours? The market impact alone will cost us tens of millions in penalties and undervalued sales."
"I don't care about the market impact, David," I said, my voice cutting through the room like a buzzsaw. "I want the cash liquid, and I want it routed into an offshore escrow account managed by the Carter Research Group by tomorrow afternoon. If any board member raises an objection, inform them that I will personally buy out their shares at a ten percent premium using my private trust."
"But what is the Carter Research Group?" David pressed, tapping his tablet frantically. "There’s no corporate registration for this entity in the state of Illinois. It’s a ghost company that hasn't filed a tax return since 2018."
"It’s the company that’s going to save my son," I said, slamming my hands flat against the glass table, causing several analysts to flinch. "The meeting is adjourned. Get it done."
I walked out of the boardroom and into my private office, where Emily was waiting for me, looking out at the foggy Chicago skyline. She held a thick, worn leather binder in her lap—the blueprint her mother had kept hidden for ten years.
"The funding is being mobilized, Emily," I said, sinking into my desk chair, feeling the crushing weight of exhaustion settling into my bones. "Now tell me where the laboratory is. If this therapy exists, why isn't it in a hospital? Why hasn't Dr. Parker heard of it?"
"Because the FDA shut it down nine years ago," Emily said, opening the binder to reveal pages of complex cellular diagrams, chemical equations, and federal regulatory stamps marked TERMINATED. "When my mother attempted to register the protocol after your wife’s death, a major pharmaceutical company—Vance Biotech—bought out the patent rights for the primary delivery enzyme. They didn't want to develop it. They wanted to bury it because it threatened their multi-billion-dollar chronic heart disease medication line."
"Richard Vance," I muttered, the name tasting like poison in my mouth. I knew Vance. He was a ruthless billionaire who had tried to muscle me out of a commercial development project in the Loop five years ago. He was a man who viewed human life as a series of recurring revenue streams.
"They kept the enzyme locked in a private containment facility in a high-security research park outside Naperville," Emily explained, pointing to a blueprint of a modern, multi-tiered laboratory complex. "My mother has the genetic sequencing codes to synthesize the therapy, but without that proprietary enzyme base, the serum will degrade within minutes of entering Ethan's bloodstream. We need to get inside that facility, Arthur. And we have exactly eleven days left before Ethan’s heart muscle undergoes irreversible cellular necrosis."
May you like
I looked at the blueprint of Vance Biotech’s facility, my mind instantly shifting from a grieving father to a tactical real estate developer who knew how to navigate every security system, every structural layout, and every legal loophole in the state.
"Richard Vance thinks he can own my wife's legacy?" I said, a cold, dangerous smile touching my lips for the first time in ten years. "He’s about to find out what happens when a man with nothing left to lose comes to collect a debt. Contact your mother, Emily. Tell her to prepare the lab equipment. We’re going to Naperville."
